Definitive Healthcare Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DH research report →
Companywww.definitivehc.com
Definitive Healthcare Corp. , together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.
- CEO
- Kevin D. Coop
- IPO
- 2021
- Employees
- 782
- HQ
- Framingham, MA, US
Price Chart
Valuation
- Market Cap
- $90.68M
- P/E
- -0.53
- P/S
- 0.38
- P/B
- 0.62
- EV/EBITDA
- 8.87
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 72.54%
- Op Margin
- 66.89%
- Net Margin
- -71.49%
- ROE
- -67.07%
- ROIC
- 40.88%
Growth & Income
- Revenue
- $241.52M · -4.24%
- Net Income
- $-138,932,000 · 66.37%
- EPS
- $-1.30 · 63.28%
- Op Income
- $-20,583,000
- FCF YoY
- -19.18%
Performance & Tape
- 52W High
- $4.70
- 52W Low
- $0.81
- 50D MA
- $1.03
- 200D MA
- $2.40
- Beta
- 1.34
- Avg Volume
- 347.44K
Get TickerSpark's AI analysis on DH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 1, 26 | Krantz Jason Ronald | other | 12,166 |
| May 1, 26 | Heller Casey | other | 1,469 |
| Apr 1, 26 | Coop Kevin | other | 37,593 |
| Apr 1, 26 | Krantz Jason Ronald | other | 45,154 |
| Mar 1, 26 | Coop Kevin | other | 175,524 |
| Feb 24, 26 | Graboske Benjamin | other | 631,068 |
| Feb 24, 26 | Paris Jonathan | other | 481,505 |
| Feb 24, 26 | Heller Casey | other | 733,301 |
| Feb 24, 26 | Coop Kevin | other | 1,735,437 |
| Feb 24, 26 | Krantz Jason Ronald | other | 242,719 |
Our DH Coverage
We haven't published any research on DH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DH Report →